Nilotinib Vs Nilotinib Plus Pegylated Interferon a (Peg-IFN) Induction and Nilotinib or Peg-IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1 Positive Chronic Myeloid Leukemia Patients in Chronic Phase (TIGER Study): The Addition of Peg-IFN Is Associated with Higher Rates of Deep Molecular Response - Hochhaus, Andreas; Burchert, Andreas; Saussele, Susanne; Baerlocher, Gabriela M.; Brummendorf, Tim H.; Rosee, Paul La; Heim, Dominik; Krause, Stefan; Le Coutre, Philipp D.; Niederwieser, Dietger; Lange, Thoralf; Fabarius, Alice; et al. (BLOOD, 2019)
CRIS-Team WoS Importer:2021-10-18